BUSINESS SUMMARY Nuvilex Inc., through its subsidiaries, engages in the research, development, and marketing of nutraceutical products in the United States and internationally. It has researched and developed a range of whole foods and nutraceutical products to help improve various health conditions, including glucose metabolism, scarring, acne, cholesterol, common cold, influenza, and other known pathogens, such as staphylococcus and streptococcus. The company’s lead product includes Cinnergen, a liquid whole food nutritional supplement that regulates blood sugar levels in Type II diabetics. It also offers Citroxin, a surface cleaner and an antiviral composition against swine influenza virus and avian influenza viruses; Cinnechol, a nutritional supplement to maintain normal cholesterol levels, as well as to support normal cardiovascular function; Cyclesurface3 cosmetics, a lipophilic surface treatment technology that is used to improve the dispersion of pigments in aqueous and organic materials; and Infinitink, a removable tattoo ink. In addition, the company provides Last Shot Hangover Remedy, a liquid nutritional supplement to help the body combat symptoms that are associated with alcohol-induced hangovers, including nausea, fatigue, and headache; Oraphyte, a nematocide; Prevorex, a liquid dietary supplement designed to help overweight individuals lose weight; purEffect, an acne treatment solution; and Talsyn-CI scar cream. It sells its products through retailers and distributors. The company was formerly known as eFoodSafety.com, Inc. and changed its name to Nuvilex Inc. in March 2009. Nuvilex Inc. is headquartered in Cherry Hill, New Jersey.